Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-10
DOI
10.3389/fimmu.2021.633167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain
- (2020) Gloria Donninelli et al. Journal of Neuroinflammation
- The role of chemokines and chemokine receptors in multiple sclerosis
- (2020) Li-Yuan Cui et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
- (2019) Simon Faissner et al. NATURE REVIEWS DRUG DISCOVERY
- Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases
- (2019) Gildas Lepennetier et al. Journal of Neuroinflammation
- Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients
- (2019) Zhile Bai et al. Frontiers in Neuroscience
- Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
- (2018) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Multiple Sclerosis: Mechanisms and Immunotherapy
- (2018) Clare Baecher-Allan et al. NEURON
- Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation
- (2018) Francesca Romana Rizzo et al. NEURAL PLASTICITY
- How far away from having an effective treatment option for progressive multiple sclerosis are we?
- (2017) Arianna Sartori et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy
- (2017) Serena Bonin et al. IMMUNOLOGICAL INVESTIGATIONS
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients
- (2017) Timur Khaibullin et al. Frontiers in Immunology
- Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis
- (2015) Mika Komori et al. ANNALS OF NEUROLOGY
- T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis
- (2015) Gabriella Ruocco et al. CLINICAL SCIENCE
- Subclinical central inflammation is risk for RIS and CIS conversion to MS
- (2015) S Rossi et al. Multiple Sclerosis Journal
- Subclinical central inflammation is risk for RIS and CIS conversion to MS
- (2015) S Rossi et al. Multiple Sclerosis Journal
- B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
- (2015) Laure Michel et al. Frontiers in Immunology
- The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention
- (2014) Joachim Burman et al. JOURNAL OF NEUROIMMUNOLOGY
- Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2014) Francesco Girolamo et al. Acta Neuropathologica Communications
- Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration
- (2013) Silvia Rossi et al. Multiple Sclerosis Journal
- Identification of a unique TGF-β–dependent molecular and functional signature in microglia
- (2013) Oleg Butovsky et al. NATURE NEUROSCIENCE
- Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
- (2013) Takuya Matsushita et al. PLoS One
- Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis
- (2013) Keith R. Edwards et al. PLoS One
- Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration
- (2012) H. Lassmann BRAIN
- CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
- (2012) Jeppe Romme Christensen et al. Multiple Sclerosis Journal
- Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation
- (2012) Bibiana Bielekova et al. PLoS One
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
- (2009) F. Sellebjerg et al. NEUROLOGY
- Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis
- (2008) Jorge Correale et al. JOURNAL OF NEUROIMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started